首页> 美国卫生研究院文献>other >Development and Validation of a Sensitive LC-MS/MS Method for the Determination of D-Serine in Human Plasma
【2h】

Development and Validation of a Sensitive LC-MS/MS Method for the Determination of D-Serine in Human Plasma

机译:用于测定人血浆中D-丝氨酸的灵敏LC-MS / MS方法的开发和验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A validated LC-MS/MS method was developed for the determination of D-Serine in human plasma. The method was fully validated for use with human plasma samples and was linear from 0.19 nmol/ml to 25 nmol/ml. The coefficient of variation was ≤ 5% for the high QC standards and ≤ 8% for the low QC standards in plasma. D-Serine and L-Serine were resolved by pre-column derivatization using (R)-1-Boc-2-piperidine carbonyl chloride as the derivatizating agent. The method was used to determine the concentration of D-Serine in plasma samples obtained in patients receiving a continuous 5-day intravenous infusion of (R,S)-ketamine. The changes in D-Ser levels varied in the 6 patients, with circulating D-Ser levels increasing as much as 35% in a patient, while decreasing 20% in a patient. While only preliminary data, the results suggests the potential importance in determining the D-Ser levels in plasma and their potential role in physiological response.
机译:开发了一种经过验证的LC-MS / MS方法来测定人血浆中的D-丝氨酸。该方法已完全验证可用于人血浆样品,并且线性范围为0.19 nmol / ml至25 nmol / ml。血浆中高QC标准的变异系数≤5%,低QC标准的变异系数≤8%。 D-丝氨酸和L-丝氨酸通过使用(R)-1-Boc-2-哌啶羰基氯化物作为衍生剂的柱前衍生来拆分。该方法用于确定接受连续5天静脉输注(R,S)-氯胺酮的患者的血浆样品中D-丝氨酸的浓度。 D-Ser水平的变化在6例患者中有所不同,循环D-Ser水平在患者中最多增加35%,而在患者中减少20%。虽然仅是初步数据,但结果表明在确定血浆中D-Ser水平及其在生理反应中的潜在作用具有潜在的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号